Search hospitals > Washington > Seattle
Fred Hutchinson Cancer Research Center
Claim this profileSeattle, Washington 98109
Global Leader in Adult T-Cell Leukemia/Lymphoma
Global Leader in Lymphoma
Conducts research for Cancer
Conducts research for Leukemia
Conducts research for Myeloid Leukemia
818 reported clinical trials
105 medical researchers
Summary
Fred Hutchinson Cancer Research Center is a medical facility located in Seattle, Washington. This center is recognized for care of Adult T-Cell Leukemia/Lymphoma, Lymphoma, Cancer, Leukemia, Myeloid Leukemia and other specialties. Fred Hutchinson Cancer Research Center is involved with conducting 818 clinical trials across 1,000 conditions. There are 105 research doctors associated with this hospital, such as Michael J Wagner, MD, Michael Schweizer, Christina S. Baik, and Jennifer M. Specht.Area of expertise
1Adult T-Cell Leukemia/Lymphoma
Global LeaderHLA positive
HLA-A positive
HLA negative
2Lymphoma
Global LeaderStage IV
Stage II
Stage III
Top PIs
Michael J Wagner, MDDana-Farber Cancer Institute5 years of reported clinical research
Studies Liposarcoma
Studies Round Cell Liposarcoma
15 reported clinical trials
19 drugs studied
Michael SchweizerFred Hutch/University of Washington Cancer Consortium1 year of reported clinical research
Expert in Prostate Cancer
Expert in Prostatic Neoplasm
14 reported clinical trials
27 drugs studied
Christina S. BaikFred Hutchinson Cancer Center6 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
12 reported clinical trials
19 drugs studied
Jennifer M. SpechtSeattle Cancer Care Alliance / University of Washington3 years of reported clinical research
Expert in Breast Cancer
Studies Breast cancer
11 reported clinical trials
20 drugs studied
Clinical Trials running at Fred Hutchinson Cancer Research Center
Breast Cancer
Breast cancer
Multiple Myeloma
Cancer
Acute Lymphoblastic Leukemia
Pancreatic Cancer
Myelodysplastic Syndrome
Prostate Cancer
Lymphoma
Adult T-Cell Leukemia/Lymphoma
Letrozole
for Breast Cancer
This stage IV trial examines how a mutation in HSD3B1 (1245C) gene affects treatment of stage I-III breast cancer. This trial may help researchers determine if mutations in HSD3B1 decreases the efficacy of aromatase inhibitor therapy such as letrozole. Letrozole may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Recruiting3 awards Phase 410 criteria
Cancer Vaccine
for Triple Negative Breast Cancer
This trial studies the effect of a special vaccine called STEMVAC, given with sargramostim, in patients with a hard-to-treat type of breast cancer. The vaccine helps the immune system recognize and attack cancer cells. The goal is to see how well the immune system responds to this treatment. STEMVAC is a type of cancer vaccine designed to stimulate the immune system to recognize and attack cancer cells.
Recruiting2 awards Phase 218 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Fred Hutchinson Cancer Research Center?
Where is Fred Hutchinson Cancer Research Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Fred Hutchinson Cancer Research Center accept?
What awards or recognition has Fred Hutchinson Cancer Research Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.